| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr15_0217500 | Intergenic-Intergenic | chr15:64826459-64826971 | chr15:64534260-64534772 | 513 nt | 0.5049 |
| hsa_chr15_0217600 | Intergenic-Intergenic | chr15:64826763-64826971 | chr15:64534564-64534772 | 209 nt | 0.4545 |
| hsa_chr15_0217700 | Intergenic-Intergenic | chr15:64827935-64837967 | chr15:64535736-64545768 | 250 nt | 0.2840 |
| hsa_ZNF609_0005200 | Intron-Intron | chr15:64829330-64831501 | chr15:64537131-64539302 | 2172 nt | 0.4443 |
| hsa_ZNF609_0005300 | Intron-Intron | chr15:64830242-64830796 | chr15:64538043-64538597 | 555 nt | 0.3297 |
| hsa_ZNF609_0005400 | Intron-Intron | chr15:64831846-64833763 | chr15:64539647-64541564 | 1918 nt | 0.4917 |
| hsa_chr15_0217800 | Intergenic-Intergenic | chr15:64835874-64836319 | chr15:64543675-64544120 | 446 nt | 0.4058 |
| hsa_chr15_0217900 | Intergenic-Intergenic | chr15:64840586-64843981 | chr15:64548387-64551782 | 250 nt | 0.3280 |
| hsa_ZNF609_0005500 | Intron-Intron | chr15:64842030-64854057 | chr15:64549831-64561858 | 126 nt | 0.4048 |
| hsa_ZNF609_0005600 | Intron-Intron | chr15:64842685-64845060 | chr15:64550486-64552861 | 2376 nt | 0.4327 |
A study in mice demonstrated that the circZNF609 exhibits higher expression in myotubes compared to myoblasts, and its downregulation reduces myoblast proliferation while inhibiting differentiation by sponging miR-194-5p and upregulating BCLAF1 [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review consolidating research across multiple species, including human, mouse, rat, and C. elegans, indicates that the circZNF609 is downregulated in Hirschsprung disease and functions as a miRNA sponge for miR-150-5p to regulate AKT3, where its silencing inhibits cell migration and proliferation [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. In mammalian neural tissue, it is also noted to play a role in myoblast differentiation by producing a protein [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].